All News

The responsibility of caregiving is increasingly being placed on family members.

I feel terror and beauty all around me, but it's OK to feel them both — they've gotten me this far.

Breast cancer and melanoma survivor reflects on coping with cancer's challenges during the holidays.

Cancer hit me with guilt the moment it came into my life. Even now, six years later, it's still part of my cancer experience.

Many patients who have had melanoma do not conduct regular skin self-examinations, and those who do check themselves do not use sufficient tools or techniques.

Those who had taken birth control pills prior to their cancer diagnosis had improved progression-free survival compared with those who had not taken contraceptives.

While recent advances in breast cancer therapy have resulted in survival gains, many patients and survivors have an increased risk of cardiovascular adverse events following treatment.

As an animal lover and psychotherapist, I've seen the healing power of pet therapy firsthand. From horses to dogs, cats and rabbits, the impact that animals have on recovery is nothing short of miraculous.

Most cancer survivors are familiar with Psalm 23 and the feeling of walking through the valley of the shadow. We also need to remember that there's another side to the valley, where the light shines brightly.

The approval was based on data from the phase 3 ELOQUENT-2 trial, in which adding Empliciti to standard Revlimid (lenalidomide)/dexamethasone reduced the risk of disease progression by 30 percent.

The treatment paradigm for patients with triple-negative breast cancer is set to undergo a dramatic transformation, as standard chemotherapeutic approaches are perfected and novel antibody-drug conjugates are developed.

Every cancer conference is a chance for me to learn.

My mother chose to live by asking for help, and so can I.

The approval was based findings from the phase 3 SQUIRE trial.

The approval was based on a substantial improvement in overall survival (OS) in a phase 3 study.

It's always something, isn't it?

As a patient advocate for those with hereditary cancer syndromes, I receive countless calls every week from women asking me about prophylactic procedures.

Pharmacies hopefully aim to help all their patients feel better, yet a common practice is making some patients feel worse. You can do something about it.

Though clinical work is ongoing and early, researchers are already considering how to manage potentially fatal neurotoxicities in patients treated with chimeric antigen receptor (CAR) T-cell therapy.

The approval was based on an extension in overall survival (OS) in the CheckMate-025 trial.

The approval was based on an extension in overall survival from two phase 3 studies.

Enjoy the holidays without the guilt.

A breast cancer and melanoma survivor shares what Thanksgiving helped teach her.

It was a night filled with inspiration, shared purpose and hope, as four heroes who have given selflessly in their efforts to improve the lives of people impacted by glioblastoma were honored at the 1st Annual Glioblastoma Multiforme (GBM) Heroes Awards.

The FDA has approved the oral medication Ninlaro in combination with Revlimid and dexamethasone for patients with multiple myeloma.

Immune checkpoint inhibitors have demonstrated encouraging results for patients with small cell lung cancer (SCLC) and mesothelioma, two aggressive thoracic malignancies with few options.

A phase 3 study exploring Zydelig in combination with Treanda and Rituxan for patients with previously treated CLL has been stopped early following a positive interim analysis.

Adding the MEK inhibitor Mekinist to the BRAF inhibitor Tafinlar significantly improves long-term outcomes while lowering certain adverse events associated with either agent alone.